Jazz Pharmaceuticals plc 10-K

Item 2. Properties Our corporate headquarters are located in Dublin, Ireland, and our U.S. operations are located in Palo Alto, California, Carlsbad, California and Philadelphia, Pennsylvania. In addition to our owned manufacturing and development facilities and our leased administrative, manufacturing and development facilities, we also have dedicated growing facilities operated by contract partners. The following table contains information about our significant properties as of December 31, 2023: Type Location Approximate Square Feet Lease / Contract Expiration Date Administrative office Dublin, Ireland 45,000 2036 Administrative office Palo Alto, United States 99,000 2029 Administrative office Philadelphia, United States 60,000 2029 Administrative office Carlsbad, United States 43,000 2028 Administrative office Oxford, United Kingdom 26,000 2028 Administrative office Cambridge, United Kingdom 22,000 2030-2031 Administrative office Vancouver, Canada 15,000 2029 Administrative office and laboratory Villa Guardia (Como), Italy 34,000 2029 Manufacturing and development Athlone, Ireland 58,000 Owned Manufacturing and development Southern United Kingdom 139,000 2024-2033 Manufacturing and development Villa Guardia (Como), Italy 45,000 Owned Growing facility Eastern United Kingdom 1,960,000 2026 Growing facility Northern United Kingdom 915,000 2025 Growing facility Southern United Kingdom 165,000 2028 Growing facility under construction Southern United Kingdom 370,000 2035 In addition, we have offices in Japan, Australia, France and elsewhere in Europe. We believe that our existing properties are in good condition and suitable for the conduct of our business. As we continue to expand our operations, we may need to lease additional or alternative facilities. Item 3. Legal Proceedings The information required to be set forth under this Item 3 is incorporated by reference to Note 14, Commitments and Contingencies—Legal Proceedings of the Notes to Consolidated Financial Statements, included in Part IV of this Annual Report on Form 10‑K. Item 4. Mine Safety Disclosures. Not applicable. 67 Table of Contents PART II